Financial Performance - Operating revenue for the first nine months of 2024 was CNY 454,685,996.92, down 16.82% from CNY 546,605,438.60 in the same period of 2023[4] - Net profit attributable to shareholders decreased by 37.29% to CNY 44,351,844.73 for the first nine months of 2024, compared to CNY 70,726,286.33 in the previous year[4] - Basic earnings per share fell by 43.28% to CNY 0.4071 for the first nine months of 2024, down from CNY 0.7177 in the same period of 2023[4] - Total profit decreased by 36.39% to CNY 50,814,583.26, mainly due to a decline in operating revenue and gross profit[7] - Total operating revenue for the first nine months of 2024 was CNY 454,685,996.92, a decrease from CNY 546,605,438.60 in the same period of 2023, representing a decline of approximately 16.7%[22] - Net profit for the first nine months of 2024 was CNY 44,351,844.73, compared to CNY 70,726,286.33 in 2023, reflecting a decrease of approximately 37%[23] - Operating profit for the first nine months of 2024 was CNY 51,823,989.76, a decline of 33% compared to CNY 77,892,791.04 in the same period of 2023[25] - Total comprehensive income for the first nine months of 2024 was CNY 45,513,368.10, down from CNY 68,576,734.02 in the first nine months of 2023[26] Cash Flow and Liquidity - Cash flow from operating activities showed a net outflow of CNY -13,761,469.80, a decline of 111.44% compared to a net inflow of CNY 120,259,540.96 in the previous year[4] - Cash flow from operating activities for the first nine months of 2024 was negative CNY 13,761,469.80, compared to positive CNY 120,259,540.96 in the same period of 2023[29] - Total cash outflow from operating activities was CNY 310,969,925.05 in the first nine months of 2024, compared to CNY 282,976,798.94 in the same period of 2023[29] - Cash and cash equivalents at the end of the first nine months of 2024 were CNY 166,020,886.74, down from CNY 242,343,863.27 at the end of the first nine months of 2023[29] - The ending cash and cash equivalents balance decreased to 153,741,014.32 CNY from 241,755,768.31 CNY, indicating a decline of 36.4%[31] - Cash inflow from financing activities was recorded at 130,461,745.28 CNY, with no comparable figure from the previous year[31] Assets and Liabilities - Total assets decreased by 30.20% to CNY 627,659,028.10 as of September 30, 2024, compared to CNY 899,242,345.79 at the end of 2023[4] - Total current assets decreased from ¥759,759,168.72 in December 2023 to ¥468,338,440.74 in September 2024, a decline of approximately 38.3%[16] - Total liabilities decreased from ¥422,637,535.10 to ¥184,730,772.23, a decline of approximately 56.3%[18] - The company's equity attributable to shareholders decreased from ¥476,604,810.69 to ¥442,928,255.87, a decline of about 7.1%[18] - The company’s total liabilities ratio decreased to 29.45% for the parent company and 29.43% for the consolidated entity, down from 47.70% and 47.00% respectively[4] - The company's total assets amounted to CNY 624,012,264.61, down from CNY 904,961,002.37, indicating a decrease of about 30.9%[21] Shareholder Information - The total number of unrestricted shares increased from 32,417,250 to 107,129,937, representing 98.33% of the total share capital[9] - The largest shareholder, Western Metal Materials Co., Ltd., holds 48,232,000 shares, accounting for 44.27% of the total shares[10] - The total share capital remains at 108,950,000 shares, with 2,741 ordinary shareholders at the end of the reporting period[9] - The number of shares held by the top ten shareholders accounts for 79.28% of the total shares[10] - There are no pledged or judicially frozen shares among the top shareholders[11] Regulatory and Compliance - The company has no ongoing litigation or arbitration matters during the reporting period[12] - The company has received an administrative regulatory measure from the Shaanxi Regulatory Bureau, but it will not significantly impact normal operations[14] - The company has implemented a corrective plan following the administrative measure received, ensuring compliance with regulatory requirements[14] Research and Development - Research and development expenses for the first nine months of 2024 were CNY 23,343,683.37, slightly down from CNY 24,166,494.46 in 2023, a decrease of about 3.4%[22]
天力复合(873576) - 2024 Q3 - 季度财报